- Jamieson Wellness entered a definitive agreement to be acquired by Kirin Holdings for C$45.75/share in cash. The deal values Jamieson at ~C$2.0B in equity value and ~C$2.5B in enterprise value, with 27% and 32% premiums to 20- and 60-day VWAPs.
- The transaction was unanimously approved by Jamieson’s Board following a Special Committee recommendation. BMO Capital Markets and Canaccord Genuity provided fairness opinions, concluding the consideration is financially fair to shareholders.
- The deal requires shareholder, court and regulatory approvals, with a Special Meeting expected in September 2026. Subject to closing conditions, the transaction is expected to close in Q4 2026, after which Jamieson will be delisted from the TSX.
- Kirin said the acquisition will expand its Health Science business into North America, while Jamieson is expected to become Kirin’s foundation in the region. The agreement includes a C$70M termination fee under certain circumstances and no financing condition.
Takeaways:
The acquisition turns Jamieson into Kirin’s North American foundation alongside Blackmores and FANCL, creating a multi‑brand global preventative health portfolio that can leverage Jamieson’s distribution, manufacturing, and brand strength in the world’s largest VMS market. For the Canadian supplement sector, it signals consolidation pressure and validates high‑quality, branded VMS assets as strategic targets for global players, while for Kirin it accelerates scale, diversifies revenue beyond Japan, and provides a base for further regional M&A and innovation.
Source: CA Newswire
